Login
$INVA
$20.93 -$0.12 (0.57%) Live

Company Executives

$INVA Management Team

Mr. Pavel Raifeld

Chief Executive Officer

Age 41
Compensation $2.716M USD
Sex Male

Mr. Mark Dipaolo

Chairman of the Board

Age 54
Compensation $380.3K USD
Sex Male

Mr. Stephen Basso

Chief Financial Officer

Age 59
Compensation $1.010M USD
Sex Male

Ms. Marianne Zhen

Chief Accounting Officer

Age 56
Compensation $967.3K USD
Sex Female
Directors
5
serving now
Independent
4 of 4
stated in the proxy; 1 not stated
Average tenure
5.4 years
from year joined
CEO also chairs the board
No
Mark A. DiPaolo
Director Age On board Independent Committees Other public boards 2025 pay Source
Mark A. DiPaolo
55 2018
8 years
Independent
Compensation
OneIM Acquisition Corp. $403,074
Jules Haimovitz
75 2018
8 years
Independent
Audit · Chair
Armata Pharmaceuticals, Inc. $447,236
Sarah J. Schlesinger, M.D.
66 2018
8 years
Independent
Nominating/Corporate Governance · Chair
Armata Pharmaceuticals, Inc. $396,851
Derek A. Small
50 2024
2 years
Independent
Compensation · Chair
None stated $383,870
Pavel Raifeld
42 2025
1 year
Not stated None stated None stated Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Mar 24, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support